Kathryn Kerisit, MD, MPH
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,881 | 131 | 99.5% |
| Education | $15.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $574.93 | 18 | $0 (2024) |
| LEO Pharma Inc. | $278.08 | 33 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $207.61 | 7 | $0 (2018) |
| Galderma Laboratories, L.P. | $201.86 | 6 | $0 (2023) |
| AbbVie, Inc. | $191.19 | 5 | $0 (2018) |
| PFIZER INC. | $180.33 | 5 | $0 (2017) |
| Aqua Pharmaceuticals | $164.43 | 9 | $0 (2017) |
| Lilly USA, LLC | $158.86 | 4 | $0 (2024) |
| Celgene Corporation | $143.86 | 9 | $0 (2018) |
| Amgen Inc. | $124.05 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.66 | 9 | GENZYME CORPORATION ($105.94) |
| 2023 | $182.87 | 4 | Galderma Laboratories, L.P. ($103.31) |
| 2022 | $33.41 | 2 | GENZYME CORPORATION ($33.41) |
| 2021 | $196.34 | 5 | GENZYME CORPORATION ($196.34) |
| 2019 | $123.69 | 1 | UCB, Inc. ($123.69) |
| 2018 | $369.78 | 11 | Novartis Pharmaceuticals Corporation ($130.01) |
| 2017 | $1,767 | 100 | LEO Pharma Inc. ($265.32) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Immunology | ||||||
| 12/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Dermatology | ||||||
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.73 | General |
| Category: Immunology | ||||||
| 08/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: Immunology | ||||||
| 05/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Immunology | ||||||
| 02/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: DERMATOLOGY | ||||||
| 02/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Immunology | ||||||
| 02/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $43.22 | General |
| Category: DERMATOLOGY | ||||||
| 11/10/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Immunology | ||||||
| 05/24/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Immunology | ||||||
| 03/28/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: Immunology | ||||||
| 03/16/2023 | Galderma Laboratories, L.P. | EPSOLAY (Drug), TWYNEO, AKLIEF | Food and Beverage | In-kind items and services | $103.31 | General |
| Category: ROSACEA | ||||||
| 06/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Immunology | ||||||
| 02/03/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Immunology | ||||||
| 09/30/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Immunology | ||||||
| 07/16/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Immunology | ||||||
| 07/02/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Immunology | ||||||
| 06/17/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Immunology | ||||||
| 06/15/2021 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 07/16/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $123.69 | General |
| Category: Immunology | ||||||
| 12/06/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $106.03 | General |
| Category: DERMATOLOGY | ||||||
| 04/10/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $117.07 | General |
| 03/06/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: DERMATOLOGY | ||||||
| 02/09/2018 | Almirall LLC | Veltin (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 425 | 683 | $258,014 | $29,272 |
| 2022 | 10 | 417 | 623 | $240,214 | $28,838 |
| 2021 | 12 | 424 | 682 | $249,283 | $33,096 |
| 2020 | 8 | 308 | 548 | $160,240 | $20,829 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 99 | $34,425 | $8,073 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 108 | $27,456 | $6,752 | 24.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 68 | 81 | $107,973 | $4,982 | 4.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 63 | 75 | $29,100 | $2,652 | 9.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 28 | 29 | $18,444 | $1,945 | 10.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $7,154 | $1,568 | 21.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $5,370 | $1,220 | 22.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 47 | 234 | $15,912 | $1,079 | 6.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 22 | 28 | $12,180 | $1,000 | 8.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 80 | $28,040 | $7,284 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 97 | $24,544 | $6,210 | 25.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 69 | 78 | $98,982 | $4,983 | 5.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 56 | 65 | $25,220 | $2,152 | 8.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $8,237 | $1,794 | 21.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $7,876 | $1,679 | 21.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 34 | 44 | $19,140 | $1,671 | 8.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 20 | 21 | $13,356 | $1,550 | 11.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 43 | 186 | $12,648 | $944.56 | 7.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 13 | $2,171 | $571.42 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 74 | $26,030 | $7,124 | 27.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 99 | $25,152 | $6,742 | 26.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 33 | 43 | $27,348 | $3,086 | 11.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 46 | 49 | $62,181 | $2,901 | 4.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $13,647 | $2,893 | 21.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 59 | 73 | $28,324 | $2,508 | 8.9% |
About Kathryn Kerisit, MD, MPH
Kathryn Kerisit, MD, MPH is a Student in an Organized Health Care Education/Training Program healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1336373729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kathryn Kerisit, MD, MPH has received a total of $2,896 in payments from pharmaceutical and medical device companies, with $222.66 received in 2024. These payments were reported across 132 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,881).
As a Medicare-enrolled provider, Kerisit has provided services to 1,574 Medicare beneficiaries, totaling 2,536 services with total Medicare billing of $112,034. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Dermatology
- Location Metairie, LA
- Active Since 05/13/2009
- Last Updated 04/30/2013
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336373729
Products in Payments
- DUPIXENT (Biological) $290.26
- COSENTYX (Biological) $207.61
- EUCRISA (Drug) $180.33
- PICATO (Drug) $146.31
- ENSTILAR (Drug) $131.77
- Enbrel (Biological) $124.05
- Cimzia (Drug) $123.69
- ATOPIC DERMATITIS - DISEASE (Drug) $104.11
- EPSOLAY (Drug) $103.31
- Otezla (Drug) $65.17
- Veltin (Drug) $59.90
- SOOLANTRA (Drug) $58.53
- VTAMA (Drug) $58.50
- Cordran (Drug) $58.46
- Humira (Biological) $54.13
- Topicort (Drug) $44.68
- EPIDUO FORTE (Drug) $40.02
- VALCHLOR MECHLORETHAMINE (Drug) $38.09
- TALTZ (Drug) $33.95
- Absorica (Drug) $32.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Metairie
Jerry Pounds
Student in an Organized Health Care Education/Training Program — Payments: $235,764
Elizabeth Grieshaber, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $156,730
Richard Morrison, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,637
Ms. Reena John, D.o,, D.O,
Student in an Organized Health Care Education/Training Program — Payments: $13,493
Tai Nguyen
Student in an Organized Health Care Education/Training Program — Payments: $11,095
Brian Peterson, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $7,380